Compound genetic abnormalities in patients with cystic fibrosis transmembrane regulator gene mutation

Compound genetic abnormalities in CFTR mutation patients can be a contributing factor when abnormal spermatogenesis is encountered. A secondary genetic etiology should be considered in these types of patients.